Bo Hu

3.3k total citations · 2 hit papers
88 papers, 2.6k citations indexed

About

Bo Hu is a scholar working on Molecular Biology, Biomedical Engineering and Inorganic Chemistry. According to data from OpenAlex, Bo Hu has authored 88 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 20 papers in Biomedical Engineering and 20 papers in Inorganic Chemistry. Recurrent topics in Bo Hu's work include RNA Interference and Gene Delivery (18 papers), Metal-Organic Frameworks: Synthesis and Applications (14 papers) and Ultrasound and Hyperthermia Applications (12 papers). Bo Hu is often cited by papers focused on RNA Interference and Gene Delivery (18 papers), Metal-Organic Frameworks: Synthesis and Applications (14 papers) and Ultrasound and Hyperthermia Applications (12 papers). Bo Hu collaborates with scholars based in China, United States and France. Bo Hu's co-authors include Yuanyu Huang, Yuhua Weng, Ling Peng, Yongxiang Zhao, Liping Zhong, Xing‐Jie Liang, Jun Zhang, Shuai Guo, Tongren Yang and Chunhui Li and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Bo Hu

80 papers receiving 2.6k citations

Hit Papers

Therapeutic siRNA: state of the art 2020 2026 2022 2024 2020 2020 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Therapeutic siRNA: state of the art
    2020 1.1k citations Bo Hu, Yuhua Weng et al. profile →
  2. The challenge and prospect of mRNA therapeutics landscape
    2020 310 citations Yuhua Weng, Chunhui Li et al. Biotechnology Advances profile →

Peers

Bo Hu
Jasmeen S. Merzaban Saudi Arabia
Jia Lv China
Wanhai Xu China
Pilar Martín‐Duque Spain
Zhixiong Cai China
Klaus Charissé United States
Tracy R. Daniels‐Wells United States
Jörg Kobarg Brazil
Di Liu China
Yan Guo China
Jasmeen S. Merzaban Saudi Arabia
Bo Hu
Citations per year, relative to Bo Hu Bo Hu (= 1×) peers Jasmeen S. Merzaban

Countries citing papers authored by Bo Hu

Since Specialization
Citations

This map shows the geographic impact of Bo Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Hu more than expected).

Fields of papers citing papers by Bo Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Hu. The network helps show where Bo Hu may publish in the future.

Co-authorship network of co-authors of Bo Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Hu. A scholar is included among the top collaborators of Bo Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Hu. Bo Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhu, Di, Yu Lu, Qian Deng, et al.. (2024). A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 67(10). 7973–7994. 12 indexed citations
3.
Ma, Yunchao, Yuxin Yao, Tianyu Zhou, et al.. (2024). A cobalt-modified covalent organic framework enables highly efficient degradation of 2,4-dichlorophenol in high concentrations through peroxymonosulfate activation. Chemical Science. 15(31). 12488–12495. 11 indexed citations
4.
Zhang, Mengjie, Abid Hussain, Bo Hu, et al.. (2024). Atavistic strategy for the treatment of hyperuricemia via ionizable liposomal mRNA. Nature Communications. 15(1). 6463–6463. 18 indexed citations
5.
6.
Yang, Li, Yang Liu, Keyan Yang, et al.. (2023). Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy. Cancer Cell International. 23(1). 281–281. 2 indexed citations
7.
Zhu, Di, Lu Yu, Bo Hu, et al.. (2023). Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils. European Journal of Medicinal Chemistry. 258. 115619–115619. 12 indexed citations
8.
9.
Niu, Li, Bo Hu, Li Zhang, & Mei Kang. (2023). Risk factors for postoperative recurrence of pT2-3N0M0 esophageal squamous cell carcinoma and patterns of its recurrence. BioScience Trends. 17(6). 475–483.
10.
Zheng, Lulu, Bo Hu, Deyao Zhao, et al.. (2023). Recent progresses of exosome–liposome fusions in drug delivery. Chinese Chemical Letters. 35(2). 108647–108647. 31 indexed citations
11.
Hu, Bo, Kun Li, Yuanyuan Liu, et al.. (2022). Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia. Science Advances. 8(7). eabm1418–eabm1418. 76 indexed citations
12.
Wang, Lu, et al.. (2021). Lipocalin 10 as a New Prognostic Biomarker in Sepsis‐Induced Myocardial Dysfunction and Mortality: A Pilot Study. Mediators of Inflammation. 2021(1). 6616270–6616270. 15 indexed citations
13.
Zhang, Jun, Yuhua Weng, Ziyang Cao, et al.. (2020). ROS-Activatable siRNA-Engineered Polyplex for NIR-Triggered Synergistic Cancer Treatment. ACS Applied Materials & Interfaces. 12(29). 32289–32300. 52 indexed citations
14.
Zhu, Xiangyu, et al.. (2020). Optimizing Soluble Expression and Inclusion Body Protein Renaturation of VP2 Protein of Mink Enteritis Virus. 41(6). 1–6. 1 indexed citations
15.
16.
Weng, Yuhua, Chunhui Li, Tongren Yang, et al.. (2020). The challenge and prospect of mRNA therapeutics landscape. Biotechnology Advances. 40. 107534–107534. 310 indexed citations breakdown →
17.
Huang, He, et al.. (2019). The effects of UDP-glycosyltransferases on chlorpyrifos susceptibility to Spodoptera exigua.. Nanjing Nongye Daxue xuebao. 42(3). 448–455. 1 indexed citations
18.
Wang, Yijia, Qing Zhou, Sheng Cao, et al.. (2017). Efficient gene therapy with a combination of ultrasound-targeted microbubble destruction and PEI/DNA/NLS complexes. Molecular Medicine Reports. 16(5). 7685–7691. 7 indexed citations
19.
Hu, Bo, et al.. (2016). Expression of the P dimer of rabbit hemorrhagic disease virus capsid protein and analysis of its binding ability to receptor.. 47(2). 325–330. 1 indexed citations
20.
Wang, Yijia, et al.. (2016). Efficient gene therapy with the combination of ultrasound targeted microbubble destruction and PEI/DNA/NLS complexes. Zhonghua chaosheng yingxiangxue zazhi. 25(10). 904–909. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jasmeen S. Merzaban Breakdown of academic impact, for papers by Jia Lv Breakdown of academic impact, for papers by Wanhai Xu Breakdown of academic impact, for papers by Pilar Martín‐Duque Breakdown of academic impact, for papers by Zhixiong Cai Breakdown of academic impact, for papers by Klaus Charissé Breakdown of academic impact, for papers by Tracy R. Daniels‐Wells Breakdown of academic impact, for papers by Jörg Kobarg Breakdown of academic impact, for papers by Di Liu Breakdown of academic impact, for papers by Yan Guo
Rankless by CCL
2026